CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,071 enrolled
Drug / intervention
Bladder diaryother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03810027
NCT03810027N/ACompleted
CompareCT.gov

Prevalence and Risk Factors of Nocturnal Polyuria in Female Overactive Bladder Syndrome

National Taiwan University Hospital·observational·Posted Jan 18, 2019·Updated Jan 18, 2019

In Brief

An observational study evaluating Bladder diary for Nocturia. Completed, enrolled 1,071 participants.

Detailed Summary

Nocturnal polyuria may decrease the treatment efficacy of overactive bladder syndrome (OAB); and adjuvant medication, such as desmopressin, may be needed for the treatment of nocturnal polyuria. The knowledge of prevalence and risk factors of nocturnal polyuria might be important for the treatment of OAB. Thus, our aim is to describe the prevalence and risk factors of nocturnal polyuria in women with OAB.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsNocturia
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJan 18, 2019
Enrollment StartJul 1, 2009
Primary CompletionJan 31, 2018
TodayJul 2, 2026
Enrollment to primary: 8.6 yearsPosted 7.5 years ago

Interventions

Bladder diaryother

3-day bladder diary